2020
DOI: 10.1016/j.phrs.2020.105118
|View full text |Cite
|
Sign up to set email alerts
|

Erythromycin has therapeutic efficacy on muscle fatigue acting specifically on orosomucoid to increase muscle bioenergetics and physiological parameters of endurance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(23 citation statements)
references
References 56 publications
1
22
0
Order By: Relevance
“…They evaluated several macrolides' effect and mechanisms in muscle endurance, in order to provide potential treatments for muscle fatigue. They demonstrated that erythromycin, dose-dependently, mitigates muscle fatigue, increases ORM levels and elevates glycogen content in muscle in a mice model [238]. Moreover, they corroborated that erythromycin enhances muscle glycogen and endurance via upregulating ORM and activating ORM-mediated CCR5-AMPK-GS pathway.…”
Section: Muscle Fatiguementioning
confidence: 75%
See 1 more Smart Citation
“…They evaluated several macrolides' effect and mechanisms in muscle endurance, in order to provide potential treatments for muscle fatigue. They demonstrated that erythromycin, dose-dependently, mitigates muscle fatigue, increases ORM levels and elevates glycogen content in muscle in a mice model [238]. Moreover, they corroborated that erythromycin enhances muscle glycogen and endurance via upregulating ORM and activating ORM-mediated CCR5-AMPK-GS pathway.…”
Section: Muscle Fatiguementioning
confidence: 75%
“…Inhibit cancer proliferation [40,134] Mitigates muscle fatigue [238] AMPK activation [238] Mitochondrial membrane potential disruption [36] ROS production [260] Cytochrome c release [261] 500 250…”
Section: Azithromycin Macrolidementioning
confidence: 99%
“…Although the value seems small, the logistic analysis based on this dataset showed that after BCT, recruits with ΔORM ≥ 0.2565 mg/mL had higher odds for suffering from severe EIF, as 5.625 times as large than those with ΔORM < 0.2565 mg/mL, which also revealed its potency as a promising biomarker. Previous studies reported that ORM could interact with skeletal muscle and inhibit protein breakdown [ 53 ], and increase muscle bioenergetics and sustain physiological endurance via upregulating the ATP production through AMPK signalling pathway [ 17 , 54 ]. When recruits felt exhausted (severe EIF during BCT), the energy supply was likely to be under compensation stage, therefore may triggered the increase of ORM.…”
Section: Discussionmentioning
confidence: 99%
“…Later, the same group showed that AGP1-CCR5 increased the activity of glycogen synthase (the ratelimiting enzyme in the glycogen synthesis pathway) via AMPKα2 (Qin et al, 2016). Further, they identified estrogens (as a negative) and erythromycin (as a positive) regulators of the AGP1-CCR5 pathway (Sun et al, 2018;Wan et al, 2020). Interestingly, Orm1-KO mice show altered metabolic parameters, such as increased levels of insulin and leptin together with impaired glucose tolerance (Sun et al, 2016) and AGP1 deficiency increases the expression of genes related to fibrosis in adipose tissue (Wang et al, 2021).…”
Section: In Vivo Approaches Transgenesis and Knockoutsmentioning
confidence: 99%
“…Later, the same group showed that AGP1-CCR5 increased the activity of glycogen synthase (the rate-limiting enzyme in the glycogen synthesis pathway) via AMPKα2 ( Qin et al, 2016 ). Further, they identified estrogens (as a negative) and erythromycin (as a positive) regulators of the AGP1-CCR5 pathway ( Sun et al, 2018 ; Wan et al, 2020 ).…”
Section: In Vivo Approaches Transgenesis and Knockoutsmentioning
confidence: 99%